Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

The sole use of stem cells in treating fracture nonunion: a scoping review

Riishede Hansen M., Ding M., Søndergaard Folkvardsen S., Gjørup Sækmose S., Kold S., Viberg B.

Systematic Review, published in Arch Orthop Trauma Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Arch Orthop Trauma Surg (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40699337
PMCID
PMC12287131
DOI
10.1007/s00402-025-05922-9
Citations
1

Abstract (original English)

Objective of this study This scoping-review aims to highlight the current modalities of sole use of stem cells in treating fracture nonunion updating a previous systematic review from 2013. We report solitary stem cell stimulation in literature in vivo studies to obtain current knowledge in understanding the crucial role of stem cells in enhancing fracture nonunion healing. Materials and methods This scoping review was conducted by systematical search in PubMed, Medline and clinicaltrials.gov with a timeframe from October 2012 to September 2024. Two authors independently screened all articles, and when included, the following information was extracted: type of nonunion, localization, type of stem cells, administered dose of stem cells, surgical information, type of scaffold, control group, evaluation method, time of evaluation post intervention, and adverse events. Results Of 4710 articles screened, 27 articles met the criteria for inclusion. In the reviewed articles, 2 out of 5 human studies, and 8 out of 12 animal studies with a control group reported a statistically significant effect of stem cells on bone healing when used in the treatment of fracture nonunion. Comparison of the studies was difficult due to heterogeneity. The administration of mesenchymal stem cells regarding adverse events was investigated in eight human studies. Conclusion Based on our reporting, the arti

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
AnimalsHumansFractures, UnunitedStem Cell TransplantationMesenchymal Stem Cell TransplantationFracture Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.